INFORMED.
LIVE

AstraZeneca Pharma India Ltd.

BSE: ASTRAZEN506820ISIN INE203A01020
  • Healthcare
  • Pharmaceuticals
  • BSE 1000

Share price

₹6,751.40+76.85 (+1.15%)
as of 18 Sep 2026
AstraZeneca Pharma India Ltd. share price, 18 Sep 2025 to 18 Sep 2026: ₹9,072.70 to ₹6,751.40 (-25.6%). Low ₹6,710.80, high ₹9,817.30. Volume shown below the price.
52W high
₹9,850.00
52W low
₹6,610.00
Off 52W high
-31.46%
1M return
-10.08%
3M return
-19.69%
6M return
-18.70%
1Y return
-25.59%
20D avg volume
575
50 DMA
₹7,582.61
200 DMA
₹8,317.39

Key ratios Standalone

Market cap
₹16,878 Cr
Current price
₹6,751.40
52W high / low
₹9,850.00 / ₹6,610.00
Face value
₹2.00
P/E
99.50
P/B
24.85
EPS (TTM)
₹67.85
Book value / share
₹271.69
ROE
24.97%
ROCE
25.50%
Operating margin
8.48%
Net margin
5.56%
Debt / equity
0.00
Net debt
₹-447.72 Cr
Interest cover
57.17
Dividend yield
0.53%
Dividend / share (TTM)
₹36.00
Payout
53.06%
Cash conversion cycle
73.6 days

Financials

MetricQ1 FY27Q4 FY26Q3 FY26Q2 FY26Q1 FY26Q4 FY25Q3 FY25Q2 FY25Q1 FY25Q4 FY24Q3 FY24Q2 FY24
Income statement
682.79578.61611.57559.09526.31480.48440.29408.00387.52383.20305.79311.07
9.235.955.136.1711.2416.157.988.158.358.669.668.37
641.03525.34571.64487.15462.49412.48372.70365.12353.46337.51295.05262.49
0.000.000.000.009.4994.2569.8877.1445.8533.6237.5238.80
304.62312.31697.12432.40417.59287.86228.76251.87240.3374.98181.53139.94
79.1645.7093.7860.4564.4566.0762.3768.0460.9657.9863.2365.27
1.952.041.060.670.720.680.330.340.110.070.610.50
5.235.603.842.5716.5717.699.079.313.913.763.703.67
107.4877.75106.5798.9785.3468.4331.3236.9540.6936.9650.8954.16
50.9959.2245.0678.1175.0684.1575.5751.0342.4154.3520.4056.96
-0.24-1.081.48-5.29-0.36-5.68-33.55-57.5616.43
50.7558.1446.5472.8274.7078.4742.0251.03-15.1654.3520.4073.38
12.8213.2613.9518.6018.8720.2211.1712.603.3714.884.6021.02
37.9344.8832.5954.2255.8358.2530.8538.43-11.7939.4815.8052.37
15.1717.9513.0421.6922.3323.3012.3415.37-4.7215.796.3220.95
Key metrics
57.9365.7851.4476.0691.9996.8451.4260.68-11.1458.1824.7177.55
8.50%11.40%8.40%13.60%17.50%20.20%11.70%14.90%-2.90%15.20%8.10%24.90%
5.60%7.80%5.30%9.70%10.60%12.10%7.00%9.40%-3.00%10.30%5.20%16.80%
6.00%8.80%9.70%
29.70%20.40%38.90%37.00%35.80%25.40%44.00%31.20%
-32.10%-23.00%5.60%41.10%573.50%47.50%95.30%-26.60%
MetricTTMFY26FY25FY24FY23FY22FY21FY20FY19FY18FY17
Income statement
2,4322,2761,7161,2961,003805.60813.56831.81728.29571.99539.57
26.4828.4940.6334.8026.1014.7612.8412.9916.2912.2519.64
2,2252,0471,5041,127854.74737.32699.31730.84671.92540.44526.01
0.009.49287.13129.0284.3889.6197.2670.2162.6727.8814.00
1,7461,8591,009499.31324.46207.88274.23169.84204.21142.16
279.09264.38257.44241.45259.10230.21216.70197.40153.53163.48
5.724.491.461.200.630.951.091.14
17.2428.5839.9914.9416.2616.9518.5814.9214.7415.83
390.77368.63241.87183.62157.35122.54115.68131.84148.66117.28118.98
233.38257.45253.15203.11174.3383.04127.09113.9672.6643.8033.20
-5.13-5.25-96.7916.43-40.23
228.25252.20156.36219.53134.1083.04127.09113.9672.6643.8033.20
58.6364.6840.6258.0334.8121.4433.7941.7518.2217.898.76
169.62187.52115.74161.5199.2961.5993.3072.2154.4425.9124.44
67.8575.0146.3064.6039.7224.6437.3228.8821.78
Key metrics
251.21285.27197.81235.67150.99100.94128.18133.6887.5858.5449.03
10.33%12.50%11.50%18.20%15.10%12.50%15.80%16.10%12.00%10.20%9.10%
6.97%8.20%6.70%12.50%9.90%7.60%11.50%8.70%7.50%4.50%4.50%
25.50%19.40%
32.60%32.50%29.20%24.50%-1.00%-2.20%14.20%27.30%6.00%
62.00%-28.30%62.70%61.20%-34.00%29.20%32.60%110.10%6.00%
-18.7563.61
-0.080.56
0.000.00
-447.72-536.14
73.658.9
Balance sheet
1,9891,518
1,7321,342
447.72536.14
213.68184.88
1,027548.50
33.8256.17
117.4763.58
782.70456.30
981.81703.00
0.000.00
0.000.00
0.000.00
872.79770.35
Cash flow
-15.1465.36
18.6930.80
-91.97-65.59
3.611.75

Compounded growth

Sales CAGR 3Y
+31.40%
Sales CAGR 5Y
+22.84%
Sales CAGR 10Y
Profit CAGR 3Y
+23.61%
Profit CAGR 5Y
+14.98%
Profit CAGR 10Y
Sales YoY (TTM)
+31.10%
Profit YoY (TTM)
-7.49%

Compounded from reported annual figures. We publish no share-price CAGR: our prices are as-traded, so one would be wrong across every split and bonus issue.

Shareholding as of 30 Jun 2026

Promoter holding
75.00%
HolderTypeHoldingPreviousChange
AstraZeneca Pharmaceuticals ABPromoter75.00%
NIPPON LIFE INDIA TRUSTEE LTD-A/C NIPPON INDIA SMALL CAP FUND(VARIOUS SCHEMES)Public2.89%
TEJAS BHALCHANDRA TRIVEDIPublic2.68%
SHIVANI TEJAS TRIVEDIPublic2.33%
ICICI PRUDENTIAL - VARIOUS SCHEMESPublic1.39%
BANDHAN - VARIOUS SCHEMESPublic1.28%
PRASHANT JAINPublic1.10%
AstraZeneca ABPromoter Group0.00%

Public shareholders are disclosed individually only above 1%.

Filings & corporate actions

Recent announcements

Corporate actions

PurposeEx dateRecord datePayment date
Final Dividend - Rs. - 36.000031 Jul 202631 Jul 2026
Dividend - Rs. - 32.000018 Jul 202518 Jul 2025
Final Dividend - Rs. - 24.00005 Jul 20245 Jul 2024

Board meetings

  • Board Meeting - Financial Results